DDX41 and myeloid neoplasm: The prevalence of DDX41 germline mutations is not known; however in a study screening 1000 myeloid neoplasm cases, DDX41 were identified in 1.5%, half of which were germline [5], suggesting that identification of a DDX41 mutation should prompt consideration of germline analysis.